Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Chronic Disease Management Platforms Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The chronic disease management platforms market has observed significant expansion in recent years. Its valuation is anticipated to climb from $8.33 billion in 2025 to $9.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. The impetus for this past growth stems from several factors, including the global rise in chronic disease cases, the increasing utilization of telehealth services, the enhancement of digital healthcare infrastructure, a heightened requirement for continuous patient monitoring, and advancements in the adoption of wearable medical devices.
The chronic disease management platforms market is set for significant expansion in the coming years. It is projected to achieve a valuation of $16.72 billion by 2030, progressing at a compound annual growth rate (CAGR) of 15.0%. This anticipated growth is influenced by the integration of AI into clinical decision support systems, the broadening of value-based healthcare models, the rise of remote patient monitoring programs, improved interoperability of healthcare data systems, and the increasing adoption of personalized medicine approaches. Prominent trends expected during the forecast period encompass AI-powered predictive chronic disease risk analytics platforms, IoT-enabled remote patient monitoring ecosystems, cloud-based interoperable electronic health record integration systems, precision medicine-driven personalized chronic care pathways, and blockchain-enabled secure patient data exchange platforms.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample_request?id=85843480&type=smp
Chronic Disease Management Platforms Market Expansion Drivers: What Is Shaping Future Growth?
The expansion of the chronic disease management platforms market is anticipated, driven by the increasing incidence of lifestyle-related ailments. These conditions refer to illnesses primarily stemming from unhealthy habits and behaviors, such as poor diet, physical inactivity, smoking, and excessive alcohol consumption. The rising occurrence of lifestyle-related diseases is attributed to growing sedentary behavior, as more individuals spend prolonged periods sitting at desks, using digital devices, and engaging in minimal physical activity. Chronic disease management platforms provide capabilities for continuous monitoring, personalized care, medication tracking, and early risk detection to aid in managing lifestyle-associated disorders including diabetes, obesity, hypertension, and cardiovascular diseases. For instance, in June 2024, the National Health Service, a UK-based government department, reported that in 2023, the NHS identified 549,000 additional individuals in England at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This figure signifies a notable increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the growing prevalence of lifestyle-related diseases is fueling the growth of the chronic disease management platforms market.
Chronic Disease Management Platforms Market Segment Breakdown: Which Categories Generate The Most Revenue?
The chronic disease management platforms market covered in this report is segmented –
1) By Type: Solutions, Services
2) By Disease Type: Cardiovascular Diseases, Diabetes, Cancer, Respiratory Diseases, Other Disease Types
3) By End User: Healthcare Providers, Healthcare Payers
Subsegments:
1) By Solutions: Population Health Management Solutions, Care Management Solutions, Patient Engagement Solutions, Telehealth Solutions, Remote Patient Monitoring Solutions, Clinical Decision Support Solutions, Healthcare Analytics Solutions
2) By Services: Consulting Services, Implementation And Integration Services, Training And Education Services, Support And Maintenance Services, Managed Services
Chronic Disease Management Platforms Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Leading companies in the chronic disease management platforms market are concentrating on creating innovative solutions, such as digital therapeutics and remote patient monitoring platforms. These efforts aim to boost patient engagement, improve medication adherence, and facilitate real-time chronic disease tracking and personalized care delivery. Digital therapeutics and remote monitoring platforms are technologically advanced healthcare solutions that integrate connected medical devices, mobile applications, cloud-based analytics, and clinical support tools to remotely oversee and manage chronic conditions. This approach offers a more proactive and data-driven alternative to traditional in-person disease management methods. For instance, in December 2025, the U.S. Food and Drug Administration (US FDA) launched the Total Product Life Cycle Advisory Program (TAP) Pilot. This initiative is designed to accelerate the development and commercialization of innovative medical devices and digital health technologies, including those for chronic disease management. The program offers early and strategic regulatory guidance, interactive feedback, and collaborative support to medical device developers throughout the entire product lifecycle. Its goal is to enhance patient access to high-quality digital healthcare technologies by streamlining regulatory pathways and improving product safety, effectiveness, and interoperability.
Chronic Disease Management Platforms Market Key Players And Strategic Industry Positioning
Major companies operating in the chronic disease management platforms market are Oracle Corporation, Koninklijke Philips N.V., Baxter International Inc., Epic Systems Corporation, Teladoc Health Inc., athenahealth Inc., Innovaccer Inc., Amwell, CareCloud Inc., Greenway Health LLC, Arcadia Solutions LLC, DarioHealth Corp., Omada Health Inc., TimeDoc Health LLC, ChartSpan Medical Technologies Inc., Vida Health Inc., HealthSnap Inc., Optimize Health Inc., CareHarmony LLC, Murphi AI Inc., Mahalo Health Inc., KangarooHealth Inc.
Access The Complete Chronic Disease Management Platforms Market Report:
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-platforms-market-report
Chronic Disease Management Platforms Market Largest Region By Revenue And Market Share
North America was the largest region in the chronic disease management platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic disease management platforms report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.